Current Diagnosing Strategies for Mycobacterium tuberculosis and its Drug Resistance: A Review.

Journal: Journal of applied microbiology
Published Date: May 2, 2025

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a major global health threat, compounded by the rise of extensively drug-resistant (XDR) and multidrug-resistant (MDR) strains. This review critically examines the current landscape of laboratory diagnostic methods for MTB, encompassing both established techniques and recent advancements. We explore the growth and genetic characteristics of MTB that underpin drug resistance development and detection. We then provide a comparative analysis of smear microscopy, culture-based methods, antigen detection, molecular diagnostics (including nucleic acid amplification tests and whole-genome sequencing), spectroscopic techniques (such as Raman spectroscopy), and mass spectrometry-based approaches. Notably, this review focuses on pathogen-based diagnostic methods, excluding host immune response assays. The strengths and limitations of each method are evaluated in terms of sensitivity, specificity, turnaround time, cost-effectiveness, and suitability for resource-limited settings. Finally, we discuss the future of TB diagnostics, emphasizing the need for integrated, multi-modal platforms, the incorporation of artificial intelligence (AI) for enhanced data analysis, and the development of affordable, point-of-care testing (POCT) to improve accessibility and impact in high-burden regions. Overcoming current diagnostic challenges is essential for improving patient outcomes and achieving global TB elimination goals.

Authors

  • Xin Mao
    Department of Chemistry, College of Sciences, Shanghai University, Shanghai 200444, China.
  • Jingkai Wang
    Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.
  • Junchi Xu
    Department of Clinical Laboratory, The Fifth People's Hospital of Suzhou, Suzhou 215163, China.
  • Ping Xu
    Department of Pharmacy, the Second Xiangya Hospital, Central South University, NO139, Renmin Road, Changsha, Hunan 410011, China.
  • Huijie Hu
    Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.
  • Li Li
    Department of Gastric Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Zhiqiang Zhang
    Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.
  • Yizhi Song
    Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals